Stemazole Promotes Oligodendrocyte Precursor Cell Survival In Vitro and Remyelination In Vivo by Yizi Zhu, Mingzhu Chen, Yubo Zhang, Mei Han

“…In conclusion, stemazole promoted OPC survival in vitro and remyelination in vivo, suggesting that this compound may be used as a therapeutic agent against demyelinating disease.…”
Get full text

MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature by Yangsa Du, Ling Xiao, Zijin Ding, Kailing Huang, Bo Xiao, Li Feng

“…Myelin-oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an autoimmune-mediated demyelinating disease of the central nervous system (CNS). …”
Get full text

Relation of Helicobacter pylori infection and multiple sclerosis in Iranian patients by Nafiseh Mohebi, Mansoureh Mamarabadi, Mehdi Moghaddasi

“…Multiple sclerosis (MS) is the most prevalent central nervous system demyelinating disease. There are known risk factors for MS. …”
Get full text

Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis by Maria V. Pinto, Adelaide Fernandes

“…Multiple sclerosis (MS) is the most common autoimmune and demyelinating disease of the central nervous system (CNS), characterized, in the majority of cases, by initial relapses that later evolve into progressive neurodegeneration, severely impacting patients’ motor and cognitive functions. …”
Get full text

Induction of Brain Tumors by the Archetype Strain of Human Neurotropic JCPyV in a Transgenic Mouse Model by Luis Del Valle, Kamel Khalili

“…JCPyV is the established opportunistic infectious agent of progressive multifocal leukoencephalopathy, a fatal demyelinating disease, which results from the cytolytic infection of oligodendrocytes. …”
Get full text

Esclerose múltipla: implicações sócio-económicas. by April Machado, Francisco Valente, Mariana Reis, Pedro Saraiva, Rita Silva, Rosa Martins, Simão Cruz, Tiago Rodrigues

“…Multiple Sclerosis (MS) is the most common demyelinating disease of the Central Nervous System. It is more frequently diagnosed in young individuals between 20 and 40 years old. …”
Get full text

The Relationship between Cognitive Dysfunction and Postural Stability in Multiple Sclerosis by Justyna Redlicka, Ewa Zielińska-Nowak, Anna Lipert, Elżbieta Miller

“…<i>Background and Objectives</i>: Multiple Sclerosis (MS) is a demyelinating disease of the central nervous system (CNS), most commonly characterized by balance dysfunction, fatigue syndrome and cognitive impairment. …”
Get full text

Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets by Xiaohong Ma, Rong Ma, Mengzhe Zhang, Baicheng Qian, Baoliang Wang, Weijing Yang

“…Multiple sclerosis (MS) is an autoimmune-mediated demyelinating disease of the central nervous system. The main pathological features are inflammatory reaction, demyelination, axonal disintegration, reactive gliosis, etc. …”
Get full text

Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis by Sugasawa Jun, Kimura Fumiharu, Sugino Masakazu, Hosokawa Takafumi, Nakajima Hideto, Hanafusa Toshiaki, Takahashi Toshiyuki

“…<p>Abstract</p> <p>Background</p> <p>Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that predominantly affects the optic nerves and the spinal cord, and is possibly mediated by an immune mechanism distinct from that of multiple sclerosis (MS). …”
Get full text

Resveratrol Neuroprotection in a Chronic Mouse Model of Multiple Sclerosis by Zoe eFonseca-Kelly, Mayssa eNassrallah, Jorge eUribe, Reas S Khan, Kimberly eDine, Mahasweta eDutt, Kenneth S Shindler

“…Results demonstrate that resveratrol prevents neuronal loss in this chronic demyelinating disease model, similar to its effects in relapsing EAE. …”
Get full text

A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis by Rachael Kee, Michelle Naughton, Gavin V. McDonnell, Owain W. Howell, Denise C. Fitzgerald

“…Multiple sclerosis (MS) is a chronic, immune-mediated, demyelinating disease of the central nervous system (CNS). …”
Get full text

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots by Robert Marschallinger, Carmen Tur, Hannes Marschallinger, Johann Sellner

“…One significant characteristic of Multiple Sclerosis (MS), a chronic inflammatory demyelinating disease of the central nervous system, is the evolution of highly variable patterns of white matter lesions. …”
Get full text

Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway by Majid Ghareghani, Majid Ghareghani, Russel J. Reiter, Kazem Zibara, Naser Farhadi

“…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). …”
Get full text

Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model by Stefan A. Berghoff, Tim Düking, Lena Spieth, Jan Winchenbach, Sina K. Stumpf, Nina Gerndt, Kathrin Kusch, Torben Ruhwedel, Wiebke Möbius, Gesine Saher

“…Together, these data have implications for understanding the role of BBB permeability in the pathogenesis of demyelinating disease.…”
Get full text

Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers by Monokesh K. Sen, Mohammed S. M. Almuslehi, Peter J. Shortland, David A. Mahns, Jens R. Coorssen

“…Multiple Sclerosis (MS) is a demyelinating disease of the human central nervous system having an unconfirmed pathoetiology. …”
Get full text

Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease by Carmen Lienert, Gabriela Schawalder, Oliver Findling, Christian P Kamm, Sebastian Humpert, Anne Mugglin, Johannes Mathis, Mathias Sturzenegger, Heinrich P Mattle

“…METHODS: Patients with a first event of presumed demyelinating disease (CIS), multiple sclerosis relapses (MS) or sub-acute disease progression were treated with a 5-day regimen of intravenous methylprednisolone (IVMP) in our inpatient clinic. …”
Get full text

Study the Effect of Melatonin on Fatigue in Patients with Multiple Sclerosis by Farzaneh Fuladi Targhi, Fardin Faraji, Ali Akbar Maleki Rad, Keyvan Ghassami, Afsoon Talaei

“…Background and Aim: Multiple Sclerosis is (MS) is a common demyelinating disease of CNS that inflammation and stress oxidative processes have an important role in clinical courses and progression of it. …”
Get full text

"Clinical Course and prognosis of 203 patients with MS in shahid Mostafa Khomeini Hospital, Tehran 2002 " by SM, Nabavi, S, Poorfarzam, H, Ghassemi

“…Background: Multiples sclerosis is a common demyelinating disease of CNS and the main cause of disability in young adults all over the world so any research in different aspects of the disease has great value. researches in Iran are few in quantity and low in sample size. …”
Get full text

Optic neuritis updates (ORP-57) by Nahid Beladi Moghadam

“…It was considered as a presentation of multiple sclerosis for decades, however Multiple sclerosis is the most common demyelinating disease associated with optic neuritis , it is important to differentiate from other auto immune processes such as NMOSD , MOGAD , GFAP-IgG-associated optic neuropathy, CRMP5-IgG-associated optic neuropathy  . …”
Get full text

The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. by Lee, M, Reddy, H, Johansen-Berg, H, Pendlebury, S, Jenkinson, M, Smith, S, Palace, J, Matthews, P

“…Although multiple sclerosis (MS) is an inflammatory demyelinating disease, there can be substantial axonal injury and loss. …”